Carcinogenesis · 2007 · 214 citations · 27 references
MedicineGeneticsOncologyEpigeneticsGene ExpressionMolecular OncologyCancer Cell SignalingCancer EpigeneticsColorectal CancerEpigenetic Alterations In CancerEpigenetic Regulation In CancerGastric CancerCancer Signaling PathwaysCanonical Wnt Beta-catenin PathwayDickkopf ProteinsEpigenetic Gene SilencingEpigenetic SilencingEpigenetics Of Gastric CancerGastrointestinal TumorsWnt In Cancer
Activation of Wnt signaling has been implicated in tumorigenesis, and epigenetic silencing of Wnt antagonist genes has been detected in various cancers. In the present study, we examined the expression and methylation of DICKKOPF (DKK) family genes in gastrointestinal cancer cell lines. We found that all known DKK genes were frequently silenced in colorectal cancer (CRC) cells (DKK1, 3/9, 33%; DKK2, 8/9, 89%; DKK3, 5/9, 56% and DKK4, 5/9, 56%), but not in normal colon mucosa. DKK1, -2 and -3 have 5' CpG islands, and show an inverse relation between expression and methylation. DKK methylation also was frequently observed in gastric cancer (GC) cell lines (DKK1, 6/16, 38%; DKK2, 15/16, 94% and DKK3, 10/16, 63%), but was seen less frequently in hepatocellular carcinoma and pancreatic cancer cell lines. DKKs also were frequently methylated in primary CRCs (DKK1, 7/58, 12%; DKK2, 45/58, 78% and DKK3, 12/58, 21%) and GCs (DKK1, 15/31, 48%; DKK2, 26/31, 84% and DKK3, 12/31, 39%). Against a background of CTNNB1 or APC mutations, Dickkopfs (Dkks) were less effective inhibitors of Wnt signaling than secreted frizzled-related proteins, though over-expression of Dkks suppressed colony formation of CRC cells with such mutations. Our results demonstrate that DKKs are frequent targets of epigenetic silencing in gastrointestinal tumors, and that loss of DKKs may facilitate tumorigenesis through beta-catenin/T-cell factor-independent mechanisms.
27
Frank Kuhnert, Corrine R. Davis, Hsiao-Ting Wang et al. · Proceedings of the National Academy of Sciences · 2003 · 620 citations · Full text
DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway
Atsushi Niida, Takatoshi Hiroko, Mana Kasai et al. · Oncogene · 2004 · 568 citations